Navigation Links
Antihistamine Could also be used as a Potential Antimalarial Drug

Researchers have found that astemizole, which is used for treating allergy can also be used as a potential drug for treating malaria//.

According to a study conducted by researchers from the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins University School of Medicine. The study, largely funded by the Johns Hopkins Malaria Research Institute (MRI), determined that in a test tube the antihistamine killed the parasite, Plasmodium falciparum, which causes malaria in humans, including parasite strains that were resistant to traditional malaria therapies. The drug was also shown to be effective in mouse models. The findings are published in the July 2, 2006, advanced online edition of Nature Chemical Biology.

“Time and money are major roadblocks when it comes to developing new drugs for the treatment of neglected diseases like malaria,” said senior study author David Sullivan, MD, an associate professor with MRI and the Bloomberg School’s W. Harry Feinstone Department of Molecular Microbiology and Immunology. “Astemizole is promising as an antimalarial, but still needs to be evaluated for effectiveness as an antimalarial in humans.”

For the study, Sullivan and colleagues Curtis Chong and Jun Liu of the Johns Hopkins School of Medicine’s Department of Pharmacology first assembled the Johns Hopkins Clinical Compound Library, which is a collection of 2,687 drugs. Seventy percent of the compounds are approved by the U.S. Food and Drug Administration, while the remaining 30 percent are approved by regulatory agencies in other countries. The researchers screened the drugs for their effectiveness in killing the malaria-causing parasite and found that astemizole was one of the more promising.

The researchers then gave astemizole, along with the drug’s major human metabolite, desmethylastemizol, to mice infected with Plasmodium. They measured 80 percent reduction in parasite counts with moderate doses of drug in
'"/>




Page: 1 2

Related medicine news :

1. Nasal Spray Beats Antihistamine
2. Antihistamine Proved Ineffective in Making Kids to Sleep
3. Travelers’ Hazard- Antihistamines Make Drowsy Driver
4. Lean Protein Could Be Key to Obesity Drugs
5. Nasal Spray Could Take Drugs Direct to Brain.
6. Nasal Spray Could Take Drugs Directly to Brain
7. Oxygen Usage During Exercise Could Indicate Heart Problems
8. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
9. Anger Could Be Linked To Weight Gain
10. A Seizure Late In Life Could be A Stroke Warning
11. New Findings Could Reduce The Extent Of Spinal Cord Injuries
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Antihistamine Could also used Potential Antimalarial Drug

(Date:9/30/2014)... September 30, 2014 The American ... to help diabetics curb their sweet tooth, but the ... this September, suggests that zero-calorie sweeteners may actually ... diabetes. , The Weizmann Institute of Science in ... artificial sweeteners to mice, the mice developed glucose intolerance. ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Hospice ... its annual “In Celebration” gala, honoring three outstanding ... mission of striving to provide extraordinary and dignified ... facing a serious or life-limiting illness. , The ... in Rye, NY and recognized William (Bill) J. ...
(Date:9/30/2014)... September 30, 2014 A group of Americans ... combat an epidemic that, left unchecked, could create a catastrophic, ... not headed to Africa. John Rogers, the Executive Director the ... Korea to fight a disease most think mankind conquered long ... 80 years ago is on the comeback in several countries ...
(Date:9/30/2014)... Clearwater, FL (PRWEB) September 30, 2014 ... (colon), declines with age, poor diet, and stress, so ... beneficial bacteria.* Each capsule of Ultimate Flora™ Men’s ... 58 billion cultures from 7 Bifidobacteria strains to support ... gas tends to build up, and 32 billion cultures ...
(Date:9/30/2014)... of Defense has made progress in reducing the stigma ... depression and post-traumatic stress disorder, but more improvement is ... , Despite efforts of both the Defense Department and ... many service members still do not seek needed care ... a concerted effort to promote treatment as a way ...
Breaking Medicine News(10 mins):Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2Health News:ReNew Life Introduces Ultimate Flora™ Men’s Complete Probiotic 90 Billion—Comprehensive Probiotic Support Just for Men 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 3
... Jan. 3 DaVita Inc. (NYSE:,DVA) announced today that ... January 7-11, 2008 at the Westin St. Francis Hotel ... will be presenting on,January 8, at 9:00 a.m. Pacific ... presentation will also be broadcast live and by replay. ...
... ... Replace Current TIME-2 ... Trial ... KOSN ) today announced that the Tanespimycin in,Myeloma Evaluation or TIME-1 pivotal Phase 3 trial for ...
... Continuing its role as a,leading supporter and ... of Preferred Provider Organizations (AAPPO) today,announced a ... that will significantly enhance benefits for members ... consumerism continue to fuel,further change in the ...
... live on surfaces for several days, experts say, , , THURSDAY, ... called the stomach flu, can be passed from one person ... computer keyboards and computer mice, U.S. health officials report. , ... most frequent cause of outbreaks of vomiting and diarrhea in ...
... Body Image, Cancer, and Breast-feeding Examined, ARLINGTON ... past scientific findings and developing new,knowledge about the ... Plastic and Reconstructive Surgery(R) (PRS), the official,medical journal ... sheds,new light on the psychological impact and health ...
... PARK, Ill., Jan. 3 Abbott (NYSE: ABT ... full year,ended Dec. 31, 2007, on Wednesday, Jan. 23, ... be followed by a live webcast of the earnings,conference ... and will be,accessible through Abbott,s Investor Relations Web site ...
Cached Medicine News:Health News:Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma 2Health News:Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma 3Health News:Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma 4Health News:Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma 5Health News:Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma 6Health News:AAPPO and HCAA Form Partnership to Enhance Services to Meet the Changing Business Needs of PPOs and TPAs 2Health News:Stomach Flu Spread By Contaminated Computer Keyboards 2Health News:Stomach Flu Spread By Contaminated Computer Keyboards 3Health News:ASPS Studies Re-Evaluate Psychological Benefits and Health Concerns of Silicone Breast Implants 2
(Date:9/30/2014)... , Sept. 30, 2014 Aileron ... Summary Global Markets Direct,s, ,Aileron Therapeutics, ... an overview of the Aileron Therapeutics, Inc.,s pharmaceutical ... comprehensive information on the current therapeutic developmental pipeline ... at various stages, therapeutics assessment by drug target, ...
(Date:9/30/2014)... -- According to their CEO, Rob Bohacs ... going through a complete transformation with highly targeted ... current clinical trial management process isn,t configured to ... which will ultimately drive the prescription cancer drugs ... been recognized by the National Cancer Institute as an ...
(Date:9/30/2014)... LOS ANGELES , Sept. 30, 2014   ... apnea shopping destination , today announced that it now ... ResMed . AirSense CPAPs are the first sleep apnea ... makes it simple and easy to track and share ... the overall effectiveness of their CPAP therapy.  In addition, ...
Breaking Medicine Technology:Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 3Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 4
... Dec. 6, 2011 Talyst, a leader in ... American Society of Health-System Pharmacists (ASHP) Midyear Clinical ... access and secure management of CII medications. AutoVault ... restocking of controlled substance inventory. AutoVault ...
... The report " Active Pharmaceutical Ingredient (API) Market ... analyzes and studies the major market drivers, restraints, and opportunities ... Rest of the world. Browse market ... Pharmaceutical Ingredient (API) Market Trends, Competitive Landscape and Global Forecasts ...
Cached Medicine Technology:Talyst Unveils AutoVault™ at ASHP 2011 2MarketsandMarkets: API Market is Expected to Reach $159.08 Billion by 2016 2MarketsandMarkets: API Market is Expected to Reach $159.08 Billion by 2016 3
Blunt tipped forceps with tungsten carbide treated jaws for enhanced gripping and removal of large sized foreign bodies....
Blunt tipped forceps with a thin tip angled at approximately 135 and hollowed out "notch" on the interior of the distal end. Tip is shaped like a pic when in the closed position. For membrane peeling...
Blunt tlpped forceps wlth smooth jaws that have been diamond dusted for enhanced grasping. Excellent for grasping of immature membranes....
Microforceps : Asymmetrical Endgripping Forceps...
Medicine Products: